HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00AGM Correction
Placing to Raise £451,250 and Director’s Dealing
Notice of AGM
Final Results
Brief: Hemogenyx Pharmaceuticals Files Annual IND Report With FDA For HG-CT-1 Car-T Therapy For AML
FDA Annual Report
Brief: Hemogenyx Pharmaceuticals' HG-CT-1 Treatment Passes Initial Safety Assessment
Recruitment of Second Patient for Clinical Trials
Conversion of convertible loan notes
Institutional investment
Brief: Hemogenyx Pharma Announces Administration Of First-In-Human Treatment With HG-CT-1
Issue of convertible loan notes
Placing to raise £340,000
Brief: Hemogenyx Pharmaceuticals Opens First Clinical Site For HG-CT-1 Trial
Ultrafast CAR-T Manufacturing
Admission of New Ordinary Shares and New ISIN
CBR Macrophage Delivery Update
Notice of Extraordinary General Meeting
IRB Approval for Phase I Clinical Trial